Regulation of non-classical protein kinase C isoenzymes in a human T cell line

C Keenan1, D Kelleher, A Long

  • 1Department of Clinical Medicine, Trinity College Dublin, St. James's Hospital, Ireland.

Insights

Novel protein kinase C (PKC) isoforms epsilon, zeta, and delta show distinct expression and activation responses in T cells. PKC zeta and delta translocate to the cytoskeleton upon T cell receptor activation, while PKC epsilon is down-regulated by phorbol 12-myristate 13-acetate (PMA).

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • Protein kinase C (PKC) isoforms are crucial regulators of T cell activation and function.
  • Atypical PKC isoforms (epsilon, zeta, delta) play significant roles in cellular signaling pathways.
  • Understanding PKC isoform dynamics is essential for deciphering T cell lymphoma pathogenesis.

Purpose of the Study:

  • To investigate the expression and activation responses of novel/atypical PKC isoforms (epsilon, zeta, delta) in the K-4 T cell lymphoma line.
  • To examine the effects of phorbol 12-myristate 13-acetate (PMA) and OKT3 (anti-CD3) activation on PKC isoform distribution.
  • To determine the impact of PMA-mediated down-regulation on PKC epsilon and zeta expression over time.

Main Methods:

  • Immunohistochemistry was used to confirm the presence and distinct expression patterns of PKC epsilon, zeta, and delta.
  • K-4 cells were treated with PMA or OKT3 for 1 hour to assess PKC isoform translocation.
  • Long-term PMA treatment (24- and 48-hour) was employed to evaluate PMA-mediated down-regulation of PKC epsilon and zeta expression.

Main Results:

  • PKC zeta expression remained unaltered by PMA treatment, while PKC epsilon was down-regulated in a concentration-dependent manner.
  • PMA activation induced PKC delta translocation from cytoplasmic/nuclear to cytoplasmic aggregates.
  • T cell receptor (TCR) activation (OKT3) led to PKC delta translocation to the cytoskeleton and PKC zeta redistribution to a cytoskeletal compartment; PKC epsilon showed no significant redistribution.

Conclusions:

  • Individual PKC isoforms exhibit distinct distribution patterns and differential responses to various stimuli (PMA vs. TCR activation).
  • These findings support the existence of discrete PKC isoform signaling pathways in T cells.
  • The study highlights the differential activation mechanisms of PKC isoforms by PMA and TCR signaling.

Related Concept Videos

Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...